Dean Chen, Director Fu, Director Ma, and Jin Yu arrived at Qinghe City Jiuhua Hospital and found Ma Mengchao of the Hepatic Tumor Surgery department.
Ma Mengchao was quite surprised by the arrival of these experts.
In his office, Ma Mengchao sat on the sofa, looking at his guests. He prepared tea for them while listening to the purpose of their visit.
Dean Chen glanced at Fu Jinfen. Of everyone present, Director Fu had the closest working relationship with Wu Ting.
Director Fu took out a stack of documents. It contained Professor Long's postoperative serum levels for ALT, TBIL, AFP, and HBV DNA, as well as Li Ai's previous postoperative follow-up information.
Wu Ting's phase-three treatment method for HBV-related primary hepatocellular carcinoma only had one case so far—Professor Long. However, a large amount of case data had already been collected for the phase-two treatment method.
Director Fu spoke to Ma Mengchao with excitement:
